News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
150,468 Results
Type
Article (8322)
Company Profile (41)
Press Release (142105)
Section
Business (45437)
Career Advice (136)
Deals (7984)
Drug Delivery (31)
Drug Development (20704)
Employer Resources (12)
FDA (4366)
Job Trends (2692)
News (80107)
Policy (8940)
Tag
Academia (496)
Allergies (28)
Alliances (15575)
Alzheimer's disease (332)
Antibody-drug conjugate (ADC) (38)
Approvals (4379)
Artificial intelligence (41)
Bankruptcy (27)
Best Places to Work (2179)
Biosimilars (68)
Biotechnology (31)
Breast cancer (55)
Cancer (492)
Career advice (119)
Cell therapy (95)
Clinical research (17019)
Collaboration (209)
Compensation (37)
COVID-19 (665)
C-suite (44)
Data (444)
Diabetes (38)
Diagnostics (1094)
Earnings (15509)
Events (17547)
Executive appointments (133)
FDA (4702)
Funding (152)
Gene therapy (83)
GLP-1 (128)
Government (1436)
Healthcare (2879)
Infectious disease (698)
Inflammatory bowel disease (53)
IPO (3198)
Job creations (602)
Job search strategy (116)
Layoffs (57)
Legal (1442)
Lung cancer (83)
Lymphoma (32)
Manufacturing (106)
Medical device (2184)
Medtech (2186)
Mergers & acquisitions (4917)
Metabolic disorders (94)
Neuroscience (418)
NextGen: Class of 2025 (880)
Non-profit (402)
Northern California (474)
Obesity (36)
Opinion (43)
Patents (34)
People (12086)
Phase I (5272)
Phase II (7116)
Phase III (6239)
Pipeline (240)
Policy (31)
Postmarket research (512)
Preclinical (1987)
Press Release (66)
Radiopharmaceuticals (56)
Rare diseases (83)
Real estate (1401)
Regulatory (6713)
Research institute (460)
Series A (37)
Southern California (497)
Startups (927)
United States (4218)
Vaccines (175)
Date
Today (35)
Last 7 days (152)
Last 30 days (639)
Last 365 days (8791)
2025 (1151)
2024 (8913)
2023 (9900)
2022 (14497)
2021 (14546)
2020 (13022)
2019 (9055)
2018 (7003)
2017 (8070)
2016 (7302)
2015 (8797)
2014 (6382)
2013 (5131)
2012 (5438)
2011 (5697)
2010 (4982)
Location
Africa (160)
Asia (25086)
Australia (3039)
California (1150)
Canada (352)
China (220)
Colorado (33)
Connecticut (32)
Delaware (31)
Europe (23952)
Florida (115)
Illinois (52)
Indiana (37)
Japan (65)
Maryland (331)
Massachusetts (769)
Minnesota (66)
New Jersey (492)
New York (334)
North Carolina (215)
Northern California (474)
Ohio (37)
Pennsylvania (191)
South America (224)
Southern California (497)
Texas (123)
Utah (31)
Washington State (83)
150,468 Results for "lattice biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication
October 21, 2024
·
1 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Press Releases
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
February 24, 2025
·
8 min read
Business
Lattice Biologics Ltd. Announces Resignation of Director
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that Mr. Donald McInnes has resigned as a director of the Company, effective immediately, so that he can focus his efforts on other professional commitments.
March 3, 2021
·
4 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
January 19, 2025
·
4 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
Drug Development
Biond Biologics Announces First Patient Dosed with BND-35 in Phase 1 Clinical Trial
Biond Biologics Ltd. today announced that the first patient has been dosed in a first-in-human clinical trial testing BND-35, a humanized ILT3/LILRB4 antagonist antibody.
June 24, 2024
·
4 min read
1 of 15,047
Next
